First author (year) | Country (Ethnicity) | Source of controls | Type of controls | Sample origin | Genotyping methods | Sample size (case/control) | Genotype frequency (case/control) | G allele frequency | HWE (Y/N) | Quality score | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
GG | GA | AA | ||||||||||
Tanabe-FRA (2008) [12] | France (European) | HB | Cirrhosis | Peripheral blood | PCR-RFLP | 44/77 | 15/12 | 17/37 | 12/28 | 39.6% | Y | 13.5 |
Tanabe-USA (2008) [12] | USA (mixed) | HB | HBV/HCV/Cirrhosis | Peripheral blood | PCR-RFLP | 59/148 | 23/32 | 27/65 | 9/51 | 43.6% | Y | 14.5 |
Qi (2009) [16] | China (Asian) | HB and PB | Healthy/HBV | Peripheral blood | PCR-RFLP | 215/380 | 102/182 | 98/160 | 15/38 | 68.9% | Y | 21 |
Wang-GX (2009) [26] | China (Asian) | HB | Healthy/HBV | Peripheral blood | PCR-RFLP | 376/477 | 190/208 | 154/221 | 32/48 | 66.8% | Y | 17.5 |
Wang-JS (2009) [26] | China (Asian) | HB | Healthy/HBV | Peripheral blood | PCR-RFLP | 186/198 | 107/93 | 65/88 | 14/17 | 69.2% | Y | 18 |
Li (2010) [31] | China (Asian) | HB and PB | Healthy/Cirrhosis | Peripheral blood | PCR-RFLP | 186/338 | 96/161 | 82/145 | 8/32 | 69.1% | Y | 19.5 |
Abu Dayyeh (2011) [29] | USA (mixed) | HB | HCV | Peripheral blood | PCR-RFLP | 66/750 | 26/178 | 25/350 | 15/222 | 47.1% | Y | 16.5 |
Chen (2011) [30] | China (Asian) | HB | Healthy/HBV/Cirrhosis | Peripheral blood | PCR-RFLP | 120/240 | 62/106 | 51/110 | 7/24 | 67.1% | Y | 19 |
Abbas (2012) [27] | Egypt (African) | HB | Healthy/HCV/Cirrhosis | Peripheral blood | PCR-RFLP | 20/60 | 7/9 | 9/28 | 4/23 | 38.3% | Y | 12 |
Cmet (2012) [33] | Italy (European) | HB and PB | Healthy/HBV | Peripheral blood | PCR-RFLP | 18/361 | 4/66 | 10/172 | 4/123 | 42.1% | Y | 16 |
Shi (2012) [28] | China (Asian) | HB | Healthy | Peripheral blood | PCR-RFLP | 73/117 | 18/13 | 31/52 | 24/52 | 33.3% | Y | 13.5 |
El-Bendary (2013) [32] | Egypt (African) | HB | HCV/Cirrhosis | Peripheral blood | PCR-RFLP | 133/105 | 57/9 | 43/36 | 33/60 | 25.7% | Y | 12 |
Suenaga (2013) [14] | Japan (Asian) | HB | Healthy/HBV/HCV | Peripheral blood or liver tissue | PCR-RFLP | 208/290 | 108/161 | 89/104 | 11/25 | 73.4% | Y | 11.5 |
Wu (2013) [15] | China (Asian) | HB and PB | Healthy/HBV | Peripheral blood | TaqMan | 404/1370 | 206/647 | 153/576 | 45/147 | 68.2% | Y | 17.5 |
Yuan-USA (2013) [13] | USA (mixed) | PB | Healthy | Peripheral blood | TaqMan | 117/225 | 28/63 | 61/102 | 28/60 | 50.7% | Y | 19 |
Yuan-CHN (2013) [13] | China (Asian) | HB | Healthy/HBV/HCV | Peripheral blood | TaqMan | 250/245 | 25/20 | 99/107 | 126/118 | 30.0% | Y | 15 |